Stay updated on APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The history now shows an updated revision entry for v3.7.0, replacing the previous v3.6.6, indicating an update to the study record.
    Difference
    0.1%
    Check dated 2026-09-20T22:49:29.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, signaling a small system update to the history page without altering study information.
    Difference
    0.1%
    Check dated 2026-08-30T21:58:46.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The history section gains a new Revision: v3.6.5 entry while removing the previous Revision: v3.6.4, updating the page's version-tracking metadata.
    Difference
    0.1%
    Check dated 2026-08-09T11:07:42.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 entry was added to the record history, and the prior Revision: v3.6.3 entry was removed. This updates the record's revision log to reflect the latest version.
    Difference
    0.1%
    Check dated 2026-07-25T23:19:00.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    Revision label on the study history page updated from v3.6.2 to v3.6.3, signaling a new build of the page. The change does not alter any study details, endpoints, or results.
    Difference
    0.1%
    Check dated 2026-07-04T13:37:23.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a small platform update and does not alter study information or navigation.
    Difference
    0.1%
    Check dated 2026-06-27T06:26:46.000Z thumbnail image

Stay in the know with updates to APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.